PMID- 23129433 OWN - NLM STAT- MEDLINE DCOM- 20140224 LR - 20220129 IS - 2047-2412 (Electronic) IS - 2047-2404 (Print) IS - 2047-2404 (Linking) VI - 14 IP - 7 DP - 2013 Jul TI - Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers. PG - 650-8 LID - 10.1093/ehjci/jes226 [doi] AB - AIMS: Hypertrophic remodelling and systolic dysfunction are common in patients with mitochondrial disease and independent predictors of morbidity and early mortality. Screening strategies for cardiac disease are unclear. We investigated whether myocardial abnormalities could be identified in mitochondrial DNA mutation carriers without clinical cardiac involvement. METHODS AND RESULTS: Cardiac magnetic resonance imaging was performed in 22 adult patients with mitochondrial disease due to the m.3243A>G mutation, but no known cardiac involvement, and 22 age- and gender-matched control subjects: (i) Phosphorus-31- magnetic resonance spectroscopy, (ii) cine imaging (iii), cardiac tagging and (iv) late gadolinium enhancement (LGE) imaging. Disease burden was determined using the Newcastle Mitochondrial Disease Adult Scale (NMDAS) and urinary mutation load. Compared with control subjects, patients had an increased left ventricular mass index (LVMI), LV mass to end-diastolic volume (M/V) ratio, wall thicknesses (all P < 0.01), torsion and torsion to endocardial strain ratio (both P < 0.05). Longitudinal shortening was decreased in patients (P < 0.0001) and correlated with an increased LVMI (r = -0.52, P < 0.03), but there were no differences in the diastolic function. Among patients there was no correlation of LVMI or the M/V ratio with diabetic or hypertensive status, but the mutation load and NMDAS correlated with the LVMI (r = 0.71 and r = 0.79, respectively, both P < 0.001). The phosphocreatine/adenosine triphosphate ratio was decreased in patients (P < 0.001) but did not correlate with other parameters. No patients displayed focal LGE. CONCLUSION: Concentric remodelling and subendocardial dysfunction occur in patients carrying m.3243A>G mutation without clinical cardiac disease. Patients with higher mutation loads and disease burden may be at increased risk of cardiac involvement. FAU - Bates, Matthew G D AU - Bates MG AD - Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK. matthew.bates@newcastle.ac.uk FAU - Hollingsworth, Kieren G AU - Hollingsworth KG FAU - Newman, Jane H AU - Newman JH FAU - Jakovljevic, Djordje G AU - Jakovljevic DG FAU - Blamire, Andrew M AU - Blamire AM FAU - MacGowan, Guy A AU - MacGowan GA FAU - Keavney, Bernard D AU - Keavney BD FAU - Chinnery, Patrick F AU - Chinnery PF FAU - Turnbull, Douglass M AU - Turnbull DM FAU - Taylor, Robert W AU - Taylor RW FAU - Trenell, Michael I AU - Trenell MI FAU - Gorman, Grainne S AU - Gorman GS LA - eng GR - G0700718/MRC_/Medical Research Council/United Kingdom GR - MR/K000608/1/MRC_/Medical Research Council/United Kingdom GR - G1100160/MRC_/Medical Research Council/United Kingdom GR - G0601943/MRC_/Medical Research Council/United Kingdom GR - CH/07/001/BHF_/British Heart Foundation/United Kingdom GR - G0800674/MRC_/Medical Research Council/United Kingdom GR - 096919/WT_/Wellcome Trust/United Kingdom GR - SRF-2011-04-017/DH_/Department of Health/United Kingdom GR - 074454/Z/04/Z/WT_/Wellcome Trust/United Kingdom GR - BH092142/WT_/Wellcome Trust/United Kingdom GR - RG/08/012/25941/BHF_/British Heart Foundation/United Kingdom PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121104 PL - England TA - Eur Heart J Cardiovasc Imaging JT - European heart journal. Cardiovascular Imaging JID - 101573788 RN - 0 (Contrast Media) RN - 0 (DNA, Mitochondrial) RN - K2I13DR72L (Gadolinium DTPA) SB - IM MH - Adult MH - Cardiomyopathies/diagnosis/genetics MH - Case-Control Studies MH - Cohort Studies MH - Contrast Media MH - DNA, Mitochondrial/*genetics MH - Female MH - Gadolinium DTPA MH - Heterozygote MH - Humans MH - Hypertrophy, Left Ventricular/*diagnosis/*genetics MH - Magnetic Resonance Imaging, Cine/methods MH - Magnetic Resonance Spectroscopy/methods MH - Male MH - Middle Aged MH - Mitochondrial Diseases/diagnosis/*genetics MH - Point Mutation MH - Prognosis MH - Reference Values MH - Statistics, Nonparametric MH - Ventricular Remodeling/*genetics/physiology PMC - PMC3681541 OTO - NOTNLM OT - Cardiac tagging OT - Cardiomyopathy OT - Magnetic resonance imaging OT - Magnetic resonance spectroscopy OT - Mitochondrial disease EDAT- 2012/11/07 06:00 MHDA- 2014/02/25 06:00 PMCR- 2012/11/04 CRDT- 2012/11/07 06:00 PHST- 2012/11/07 06:00 [entrez] PHST- 2012/11/07 06:00 [pubmed] PHST- 2014/02/25 06:00 [medline] PHST- 2012/11/04 00:00 [pmc-release] AID - jes226 [pii] AID - 10.1093/ehjci/jes226 [doi] PST - ppublish SO - Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):650-8. doi: 10.1093/ehjci/jes226. Epub 2012 Nov 4.